Antibiotic spacer knee: Definition, Uses, and Clinical Overview

Posted on February 28, 2026 | by drknee

Antibiotic spacer knee Introduction (What it is)

An Antibiotic spacer knee is a temporary implant placed inside the knee joint that contains antibiotics.
It is most commonly used during treatment of a knee joint infection related to a knee replacement.
It helps maintain joint space and deliver medication locally while infection is being addressed.
In many care plans, it is a bridge between surgeries rather than a final, permanent implant.

Why Antibiotic spacer knee used (Purpose / benefits)

An Antibiotic spacer knee is used when a knee joint needs infection management and mechanical “placeholder” support at the same time. The most common setting is a periprosthetic joint infection (PJI)—an infection involving a knee replacement (total knee arthroplasty). In this situation, clinicians may remove infected implants and then place a spacer to stabilize the knee and deliver antibiotics directly within the joint area.

Key goals and potential benefits include:

Local antibiotic delivery: The spacer material (often bone cement) can be mixed with antibiotics. This allows high local exposure near infected tissues while systemic (whole-body) antibiotics are managed separately.
Maintaining joint space and soft-tissue tension: After implant removal, the knee can shorten or scar down. A spacer helps keep the space open and preserves soft-tissue length, which can matter for later reconstruction.
Improving comfort and basic function: Compared with having no implant at all, a spacer may reduce pain from bone-on-bone contact and can provide a degree of stability. The level of mobility varies by spacer type and clinical plan.
Supporting staged surgical strategies: In a common “two-stage” approach, the spacer is used temporarily while infection treatment progresses, with later conversion to a new knee implant if appropriate.
Helping clinicians reassess infection control: The spacer period is often used to monitor symptoms, laboratory trends, wound healing, and overall readiness for the next step. Exact protocols vary by clinician and case.

Indications (When orthopedic clinicians use it)

Orthopedic teams may consider an Antibiotic spacer knee in situations such as:

Infection involving a prior knee replacement (periprosthetic joint infection)
Chronic or difficult-to-treat infection where implant removal is part of the plan
Prior failed infection treatment, including recurrence after earlier procedures
Significant joint contamination identified during revision surgery
Selected severe knee joint infections where temporary joint reconstruction is preferred before definitive surgery (varies by clinician and case)
Situations where maintaining knee length, alignment, or soft-tissue tension is important while infection is treated

Contraindications / when it’s NOT ideal

An Antibiotic spacer knee may be less suitable, or require alternative strategies, in situations such as:

Medical instability or inability to tolerate surgery/anesthesia, where a staged surgical pathway is not feasible
Severely compromised soft tissues around the knee (poor skin coverage, complex wound problems) where healing is uncertain and different reconstructive plans may be needed
Extensor mechanism disruption (quadriceps tendon/patellar tendon mechanism) that makes knee stability and function difficult with a spacer (approach varies by clinician and case)
Major bone loss or severe instability where a typical spacer may not provide adequate structural support without specialized constructs
Known allergy or intolerance to spacer components (e.g., certain antibiotics or bone cement ingredients), requiring a different formulation or approach
Organism- or case-specific considerations, such as unusual pathogens or resistance patterns that affect antibiotic selection (management varies by clinician and case)
Situations where a different overall pathway is chosen, such as single-stage revision, arthrodesis (fusion), long-term nonoperative suppression, or other salvage strategies, depending on goals and risks

How it works (Mechanism / physiology)

At a high level, an Antibiotic spacer knee works through two parallel functions: local infection control support and temporary biomechanics.

Local antibiotic delivery (physiology)

Many spacers are made from polymethylmethacrylate (PMMA) bone cement that has been mixed with one or more antibiotics. After implantation:

Antibiotic can elute (release) from the cement into nearby joint fluid and tissues.
This creates high local concentrations near the infection site while systemic antibiotics may be given separately.
The exact release profile depends on spacer design, cement type, antibiotic choice, dose, mixing method, and manufacturer or surgeon technique. It varies by clinician and case.

This is not “self-contained infection cure.” Instead, it is typically one part of a broader infection-management plan that may also include surgical cleaning (debridement), removal of infected material, and systemic antimicrobial therapy coordinated with infectious disease specialists.

Temporary joint mechanics (biomechanics)

When a knee replacement is removed, the femur (thigh bone) and tibia (shin bone) can be left without their usual bearing surfaces. A spacer helps by:

Maintaining joint space between the femur and tibia
Helping preserve alignment and limiting extreme instability
Reducing painful contact between bony surfaces
Potentially allowing controlled motion in some spacer designs

Relevant knee structures include:

Femur and tibia: primary load-bearing bones across the joint
Patella (kneecap): interacts with the femur through the patellofemoral joint; tracking can be affected by swelling, scarring, or spacer geometry
Collateral ligaments and capsule: key stabilizers that can stiffen or become lax depending on infection damage, surgery, and spacer type
Meniscus and cartilage: typically not present in an arthritic knee replacement setting, but the surrounding soft tissues still influence stability and motion

Onset, duration, and reversibility

Onset: The spacer’s mechanical role begins immediately after implantation. Antibiotic elution begins soon after placement, with the release pattern changing over time.
Duration: Spacers are usually temporary. How long they remain in place depends on infection response, soft-tissue healing, systemic treatment course, and surgical planning—this varies by clinician and case.
Reversibility: The spacer is intended to be removable if a later definitive reconstruction is performed.

Antibiotic spacer knee Procedure overview (How it’s applied)

An Antibiotic spacer knee is not a single “office procedure.” It is typically part of a surgical treatment pathway, often during revision surgery for infection. A simplified overview looks like this:

Evaluation and exam – Review of symptoms (pain, swelling, drainage), prior surgeries, medical history, and risk factors. – Physical exam focusing on wound condition, stability, range of motion, and neurovascular status.
Imaging and diagnostics – X-rays are commonly used to assess implants, alignment, and bone changes. – Laboratory testing and joint aspiration (drawing joint fluid) may be used to evaluate for infection. Specific tests vary by clinician and case.
Preparation – Surgical planning includes spacer type, antibiotic selection, and soft-tissue considerations. – Coordination with infectious disease specialists may guide antimicrobial choices.
Intervention (operative stage where the spacer is placed) – Removal of infected implant components when indicated. – Thorough debridement (cleaning of infected/necrotic tissue) and irrigation. – Placement of the antibiotic-loaded spacer to maintain joint space and deliver local antibiotics.
Immediate checks – Assessment of knee stability, alignment, wound closure quality, and early postoperative status. – Early postoperative imaging may be used to document spacer position (practice varies).
Follow-up and rehabilitation – Monitoring of wound healing, symptoms, and relevant lab trends. – A rehab plan may address mobility, strength, and safe movement within surgeon-defined limits. – Later decision-making may include spacer exchange, conversion to a new knee implant, or other pathways depending on infection control and tissue status.

Types / variations

Antibiotic spacers for the knee vary by design goal, degree of motion allowed, and how they are manufactured.

Static (non-articulating) spacers

Designed to limit motion and provide a block-like separation between femur and tibia.
Often used when maximizing stability is prioritized, such as with major soft-tissue compromise, severe instability, or complex bone loss (selection varies by clinician and case).
Tradeoff: can contribute to stiffness and make later motion recovery more challenging in some patients.

Articulating (mobile) spacers

Designed to allow controlled knee bending and more functional movement.
May help maintain range of motion and make walking/rehab easier for selected patients.
Designs include cement-on-cement, metal/plastic components combined with antibiotic cement, or other constructs depending on system and surgeon preference.

Custom-made vs prefabricated systems

Custom-made spacers: assembled during surgery using antibiotic-loaded cement molded to patient needs.
Prefabricated spacers: manufactured components designed for standardized sizing; antibiotic addition and specifics vary by product and protocol.

Antibiotic formulation variations

The spacer may contain single or multiple antibiotics.
Antibiotic choice is typically guided by culture results, suspected organisms, allergy history, local protocols, and infectious disease input. Elution and mechanical properties can vary by antibiotic type and dose.

Temporary vs extended-use spacers

Most are intended as temporary devices before definitive reconstruction.
In select complex cases, a spacer may remain longer than initially planned due to medical factors or surgical decision-making. This is case-dependent.

Pros and cons

Pros:

Provides local antibiotic delivery directly at the surgical site
Helps maintain joint space and soft-tissue tension after implant removal
Can improve comfort compared with an unreconstructed joint space (varies by case)
May offer some stability and, with articulating designs, some mobility
Supports staged strategies where infection control is addressed before definitive reconstruction
Can simplify later reconstruction by preserving alignment and limiting scarring (varies by tissue condition)

Cons:

Typically requires at least one additional surgery if definitive reimplantation is planned
Risk of spacer-related mechanical problems (migration, fracture, wear, instability), depending on design and patient factors
Potential for stiffness and loss of range of motion, especially with static spacers
Ongoing risk of persistent or recurrent infection, even with appropriate treatment
Possibility of systemic side effects related to antibiotics or overall treatment course (risk varies by drug and patient health)
Rehab and weight-bearing restrictions may be needed, which can affect independence and work activities (varies by clinician and case)

Aftercare & longevity

Aftercare following placement of an Antibiotic spacer knee generally focuses on protecting the knee, supporting safe mobility, monitoring infection response, and preparing for the next phase of treatment. Because protocols differ, the specifics (including weight-bearing status and therapy intensity) vary by clinician and case.

Factors that can influence the spacer period and overall outcome include:

Severity and type of infection: organism characteristics, tissue involvement, and prior treatment history can affect the course.
Soft-tissue condition: wound healing quality and scar formation influence function and readiness for additional surgery.
Bone stock and stability: bone loss and ligament/capsule integrity affect how stable the spacer feels and how safely the knee can be loaded.
Rehabilitation participation: guided therapy may focus on safe transfers, gait mechanics, maintaining strength, and (when allowed) preserving motion.
Adherence to follow-up: repeated clinical assessments and lab monitoring are often used to track progress.
Comorbidities: diabetes, vascular disease, kidney disease, immune suppression, and smoking history (among others) can influence healing and infection control.
Device/material variables: spacer design (static vs articulating), cement formulation, and antibiotic selection can affect both mechanical behavior and antibiotic release. These choices vary by clinician and case.

“Longevity” is somewhat different here than with a permanent knee replacement. A spacer is usually not designed for years of high-demand activity. When it remains in place longer than planned, it is generally due to complex medical or surgical decision-making rather than as a standard long-term solution.

Alternatives / comparisons

The right comparison depends on the underlying problem being treated (most often infection after knee replacement) and the patient’s overall health and goals. Common alternatives or related strategies include:

Debridement, antibiotics, and implant retention (DAIR): In selected cases—often earlier infections—surgeons may clean the joint and exchange certain modular parts without removing the entire implant. This avoids a spacer but is not appropriate for every infection pattern.
Single-stage revision (one-stage exchange): The infected implant is removed and a new one is placed in the same surgery, paired with antibiotics. This approach is used in selected patients and centers; candidacy varies by organism, tissue condition, and surgeon protocol.
Two-stage revision without an articulating spacer: Some pathways use a static spacer or other methods to manage space and infection risk. The tradeoff can be reduced mobility during the interim.
Resection arthroplasty (implant removal without reconstruction): Rarely used as a definitive option in knees because function can be very limited, but it may be considered in complex salvage scenarios.
Arthrodesis (knee fusion): Can provide a stable, pain-reduced limb in selected severe or recurrent infections, but eliminates knee motion.
Amputation (salvage): Considered in extreme cases where infection control or limb function cannot be achieved otherwise; it is not a typical pathway.
Long-term suppressive antibiotics (noncurative management): In select patients who are not candidates for major surgery, clinicians may use suppressive antibiotic therapy. This can reduce symptoms or progression but does not necessarily eradicate infection and requires careful monitoring.

Compared with these alternatives, an Antibiotic spacer knee is most often a temporary, staged tool that balances local infection management with maintaining the option for later reconstruction.

Antibiotic spacer knee Common questions (FAQ)

Q: Is an Antibiotic spacer knee the same as a knee replacement?
No. It is usually a temporary device used during infection treatment, often after a knee replacement has been removed. A permanent knee replacement is designed for long-term joint function, while a spacer is typically a bridge to the next step.

Q: Will the knee be painful with a spacer?
Pain experiences vary widely based on infection severity, tissue inflammation, spacer type, and individual factors. Some people feel improved pain compared with the infected implant state, while others still have significant discomfort during healing and rehabilitation.

Q: Do you need anesthesia for spacer placement?
Spacer placement is commonly done during an operative procedure, so anesthesia is typically used. The type of anesthesia and pain-control plan depends on patient health and the surgical team’s approach.

Q: How long does an Antibiotic spacer knee stay in?
There is no single timeline. The duration depends on infection response, wound healing, systemic antibiotic course, and surgical planning, and it varies by clinician and case.

Q: Can you walk or put weight on the leg with a spacer?
Sometimes partial or modified weight-bearing is allowed, and sometimes stricter limits are used. This depends on spacer design, bone quality, stability, and soft-tissue status, so instructions vary by clinician and case.

Q: Can you bend your knee with an antibiotic spacer?
With an articulating spacer, bending is often part of the intended function, though motion may still be limited by swelling, pain, and scar tissue. With a static spacer, motion is usually more restricted by design.

Q: Is it safe to drive or return to work with a spacer?
Driving and work readiness depend on pain control, mobility, medication effects, leg strength, reaction time, and the type of work. Clearance policies vary by clinician and case, and may also depend on which leg is involved.

Q: What are the main risks or complications?
Potential issues include persistent or recurrent infection, wound healing problems, stiffness, instability, spacer migration or breakage, blood clots, and side effects from antibiotics. Individual risk depends on health conditions, organism factors, and surgical complexity.

Q: What antibiotics are inside the spacer?
Antibiotic selection is typically based on suspected or confirmed organisms, allergy history, and local protocols, often with infectious disease input. The specific antibiotic(s) and dosing can vary by clinician and case and by cement/material system.

Q: What does an Antibiotic spacer knee cost?
Costs vary widely depending on the hospital setting, region, insurance coverage, surgical complexity, and whether additional procedures are needed. It is usually part of a broader surgical and infection-treatment episode rather than a standalone purchase.